Alpha 2.0
Login Register
» Authors » P M Patel

P M Patel

Explore the profile of P M Patel including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 312
Citations 911
Followers 0
Related Specialties
Biophysics
Anesthesiology
Oncology
Top 10 Co-Authors
S Prell
C P Jessop
J G Smith
W T Ford
J P Lees
P Kim
M A Giorgi
W S Lockman
B Spaan
J Chauveau
Published In
Phys Rev Lett
Anesthesiology
J Neurosurg Anesthesiol
Anesth Analg
Br J Cancer
Affiliations
Soon will be listed here.
Recent Articles
1.
Reduction of calcified plaque volume in ex vivo pericardial tissue, with nanobubbles
Li A, Li Y, Qiu S, Patel P, Chen Z, Earthman J
Colloids Surf B Biointerfaces . 2022 Jul; 217:112666. PMID: 35797774
The present research investigated the effect of nanobubbles in Ringer's solution on calcified plaque within ex vivo coronary and peripheral artery tissue. The goal of the work was to determine...
2.
Assessing the risk factors for anxiety, depression and post-traumatic stress disorder through the International Pemphigus and Pemphigoid Foundation
Patel P, Jones V, Kridin K, Strong R, Yale M, Amber K
J Eur Acad Dermatol Venereol . 2021 Sep; 36(2):e139-e141. PMID: 34551175
No abstract available.
3.
'Hidradenitis suppurativa and amyloidosis: a possible association with the pyrin inflammasome': reply from authors
Kridin K, Patel P, Amber K, Cohen A
Clin Exp Dermatol . 2021 Apr; 46(6):1118-1119. PMID: 33908073
No abstract available.
4.
Direct Immunofluorescence Findings in 145 Consecutive Patients Receiving a Conjunctival Biopsy for Cicatrizing Conjunctivitis
Kneiber D, Kowalski E, Kroloff M, Patel P, Jones V, Tu E, et al.
Ocul Immunol Inflamm . 2020 May; 29(7-8):1478-1479. PMID: 32469634
No abstract available.
5.
Complete remission on minimal therapy vs. off therapy: for what should we be aiming in pemphigus?
Jones V, Patel P, Amber K
J Eur Acad Dermatol Venereol . 2020 Mar; 34(8):e404-e405. PMID: 32124498
No abstract available.
6.
Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial
Corrie P, Marshall A, Nathan P, Lorigan P, Gore M, Tahir S, et al.
Ann Oncol . 2019 Aug; 30(12):2013-2014. PMID: 31430371
No abstract available.
7.
Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) ocular melanoma study
Khoja L, Atenafu E, Suciu S, Leyvraz S, Sato T, Marshall E, et al.
Ann Oncol . 2019 Jun; 30(8):1370-1380. PMID: 31150059
Background: Despite the completion of numerous phase II studies, a standard of care treatment has yet to be defined for metastatic uveal melanoma (mUM). To determine benchmarks of progression free...
8.
Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial
Corrie P, Marshall A, Nathan P, Lorigan P, Gore M, Tahir S, et al.
Ann Oncol . 2018 Jul; 29(8):1843-1852. PMID: 30010756
Background: Bevacizumab is a recombinant humanised monoclonal antibody to vascular endothelial growth factor shown to improve survival in advanced solid cancers. We evaluated the role of adjuvant bevacizumab in melanoma...
9.
Inhibition of RhoA reduces propofol-mediated growth cone collapse, axonal transport impairment, loss of synaptic connectivity, and behavioural deficits
Pearn M, Schilling J, Jian M, Egawa J, Wu C, Mandyam C, et al.
Br J Anaesth . 2018 Mar; 120(4):745-760. PMID: 29576115
Background: Exposure of the developing brain to propofol results in cognitive deficits. Recent data suggest that inhibition of neuronal apoptosis does not prevent cognitive defects, suggesting mechanisms other than neuronal...
10.
Inhibition of p75 neurotrophin receptor does not rescue cognitive impairment in adulthood after isoflurane exposure in neonatal mice
Schilling J, Kassan A, Mandyam C, Pearn M, Voong A, Grogman G, et al.
Br J Anaesth . 2017 Oct; 119(3):465-471. PMID: 28969308
Background: Isoflurane is widely used for anaesthesia in humans. Isoflurane exposure of rodents prior to post-natal day 7 (PND7) leads to widespread neurodegeneration in laboratory animals. Previous data from our...